Cytology and Human Papillomavirus Testing 6 to 12 Months after ASCUS or LSIL Cytology in Organized Screening To Predict High-Grade Cervical Neoplasia between Screening Rounds

Comparison of Seven Tests for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears: the Predictors 2 Study

(2012) Anne Szarewski et al.   JOURNAL OF CLINICAL MICROBIOLOGY

HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study

(2011) R S Kelly et al.   BRITISH JOURNAL OF CANCER

Use of HC2 to triage women with borderline and mild dyskaryosis in the UK

(2011) M Arbyn et al.   BRITISH JOURNAL OF CANCER

Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia

(2011) Ameli Tropé et al.   GYNECOLOGIC ONCOLOGY

Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2–3 in follow up biopsies and spontaneous regression of CIN2–3

(2011) Irene T. Ovestad et al.   GYNECOLOGIC ONCOLOGY

Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening

(2011) Dorien C. Rijkaart et al.   INTERNATIONAL JOURNAL OF CANCER

Sensitivity, Specificity, and Clinical Value of Human Papillomavirus (HPV) E6/E7 mRNA Assay as a Triage Test for Cervical Cytology and HPV DNA Test

(2011) Maria Benevolo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Human Papillomavirus Testing in the Prevention of Cervical Cancer

(2011) Mark Schiffman et al.   JNCI-Journal of the National Cancer Institute

The Clinical Meaning of a Cervical Intraepithelial Neoplasia Grade 1 Biopsy

(2011) Philip E. Castle et al.   OBSTETRICS AND GYNECOLOGY

HPV mRNA tests for the detection of cervical intraepithelial neoplasia: A systematic review

(2010) E.A. Burger et al.   GYNECOLOGIC ONCOLOGY

Randomized healthservices study of human papillomavirus-based management of low-grade cytological abnormalities

(2010) Lena Dillner et al.   INTERNATIONAL JOURNAL OF CANCER

Aptima HPV E6/E7 mRNA Test Is as Sensitive as Hybrid Capture 2 Assay but More Specific at Detecting Cervical Precancer and Cancer

(2010) S. Ratnam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

HPV mRNA test in women with minor cervical lesions: Experience of the University Hospital of North Norway

(2010) S.W. Sorbye et al.   JOURNAL OF VIROLOGICAL METHODS

Triage of Women with Minor Cervical Lesions: Data Suggesting a “Test and Treat” Approach for HPV E6/E7 mRNA Testing

(2010) Sveinung Wergeland Sørbye et al.   PLoS One

A Study of Amplicor Human Papillomavirus DNA Detection in the Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion Triage Study

(2009) N. Wentzensen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate

(2009) Marc Arbyn et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Performance of Human Papillomavirus DNA and mRNA Testing Strategies for Women with and without Cervical Neoplasia

(2009) A. Trope et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Validation of high-risk HPV tests for primary cervical screening

(2009) C.J.L.M. Meijer et al.   JOURNAL OF CLINICAL VIROLOGY

Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening

(2009) P. Naucler et al.   JNCI-Journal of the National Cancer Institute

Comparison of Predictors for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears

(2008) A. Szarewski et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1

(2008) J. Jordan et al.   CYTOPATHOLOGY

Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

(2008) Inger Kristin Larsen et al.   EUROPEAN JOURNAL OF CANCER

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER